Gleamervs
Annalise.ai
Annalise.ai: If chest X-ray and head CT triage matter more than musculoskeletal trauma
Gleamer
CE marked and FDA cleared imaging AI suite for bone trauma and chest, now owned by RadNet
As of 1 September 2026, Gleamer's pricing is not published; the vendor quotes on request. Gleamer sells BoneView for fracture detection and a widening suite across chest, CT, mammography and MRI, bundled as Gleamer Copilot. Softwr lists it under Healthcare. Gleamer is made by Gleamer SAS, a RadNet company, available on Web, Self-hosted.
Overview
What Gleamer does
Gleamer is a Paris based radiology AI company whose first and best known product is BoneView, an algorithm that flags fractures, dislocations and joint effusions on plain radiographs. The portfolio has grown to ChestView for thoracic pathology on X-ray, BoneAge, BoneMetrics for musculoskeletal measurement, LungCT for pulmonary nodules, BreastView for mammography and, through the Pixyl acquisition, neuro MRI volumetry and multiple sclerosis lesion tracking. These are sold together as Gleamer Copilot with a single integration point, and the company has added AutoReport and voice reporting on top. The fact that should change a shortlist is ownership. In February 2026 RadNet, the largest outpatient imaging operator in the United States, agreed to acquire Gleamer for around two hundred and fifteen million euros upfront. RadNet already owns DeepHealth, which sells competing imaging AI, and RadNet also competes directly with independent imaging centres that are Gleamer customers. Buyers should ask explicitly how the Gleamer and DeepHealth portfolios will be rationalised and whether pricing or roadmap priority will favour RadNet-owned sites. Buyers are emergency departments, urgent care and musculoskeletal services, particularly in Europe where BoneView has been deployed at scale in national settings. Clinical validation is the strongest part of the case: multi-reader studies published in Radiology reported meaningful improvement in reader sensitivity for fracture detection and a reduction in false negatives, with the largest gain among less experienced readers and in emergency settings. The trade off is that the gain is concentrated where reader expertise is lowest, so a specialist musculoskeletal service reading its own plain films will see far less benefit than an emergency department where junior doctors read first.
What people use it for
- An emergency department where junior doctors read plain films before radiology review and missed fractures are a recurring incident theme
- An urgent care network standardising musculoskeletal reading quality across sites with variable radiology cover
- A paediatric service automating bone age assessment to remove a slow manual atlas comparison
- An orthopaedic service that needs automated limb alignment and measurement before surgical planning rather than manual measurement on the workstation
Related searches
The honest half
Where it falls short
Concrete and checkable, so you can decide whether any of them matter to you. This is the half of a review a vendor will not write about Gleamer.
- RadNet, an imaging provider that competes with many independent Gleamer customers, now owns the company and also owns the competing DeepHealth AI portfolio, so roadmap and pricing priorities are an open question for non-RadNet buyers.
- The measured benefit is largest for less experienced readers, so a specialist musculoskeletal service will see far less improvement than the published reader studies suggest.
- Cleared indications differ per module and per market, and the FDA cleared set is narrower than the CE marked European set, so an American buyer cannot rely on European reference sites.
- Each additional module adds alert volume into the same worklist, and departments running several Gleamer algorithms report needing local threshold tuning to keep radiologist trust.
- Pricing is per exam and not published, which makes budgeting difficult for an emergency department whose plain film volume swings seasonally.
Cross-shopped
What people choose instead of Gleamer
Each pairing was judged by two reviewers asking whether a buyer would genuinely weigh the two against each other. The ones that failed were deleted rather than published.
- GleamervsRad AI
Rad AI: If the constraint is reporting throughput rather than detection accuracy
- GleamervsSectra
Sectra: If you prefer to procure algorithms through your imaging platform marketplace rather than direct
Pricing
What Gleamer costs
Taken from the vendor's own pricing page. Prices move, so check before you buy.
Gleamer Copilot
On request
- Priced per exam analysed or as an annual volume subscription
- Modules licensed individually or bundled as Copilot
- Cleared and CE marked indication differs per module and per market
- On-premise deployment quoted separately from cloud
Capabilities
Features
BoneView
Fracture, dislocation and joint effusion detection on plain radiographs
ChestView
Thoracic pathology detection on chest X-ray
BoneAge
Automated bone maturity assessment from hand radiographs
BoneMetrics
Automated musculoskeletal measurement for orthopaedic planning
LungCT and BoneCT
Pulmonary nodule and secondary bone lesion detection on CT
BreastView
Breast lesion detection on mammography
Pixyl.Neuro
Brain volumetry and multiple sclerosis lesion tracking on MRI
Gleamer Copilot
Single gateway and integration point across all modules
Answered, with sources
Questions people ask
Each answer names the page it came from, so you can check it rather than take our word for it.
Who owns Gleamer?
RadNet agreed to acquire Gleamer in February 2026 for around two hundred and fifteen million euros upfront. RadNet also owns DeepHealth, a competing AI portfolio.
Is BoneView FDA cleared?
Yes, BoneView holds 510(k) clearance including for paediatric fracture detection, but the cleared finding set is narrower than the CE marked indication in Europe.
What does the evidence actually show?
Multi-reader studies reported improved reader sensitivity for fracture detection and fewer false negatives, with the gain concentrated among less experienced readers in emergency settings.
Can I buy just BoneView?
Yes, modules are licensed individually, though the commercial pitch is now the Copilot bundle across modalities.
Keep looking
Where to go from Gleamer
- Gleamer alternativesEvery product people weigh against it
- Gleamer pricingPlans, floors and what the tiers exclude
- Gleamer badgesWhich rules it meets, and the figure behind each
- All Healthcare softwareThe full category
- Best Healthcare softwareThe shortlist, and how it was cut
Best Healthcare software for
Compare Gleamer with
- Annalise.ai
- Sectra
- Rad AI
- Lunit
- Techcyte
- Philips IntelliSpace PACS
- Visage Imaging
- Paige
- Therapixel
- Fujifilm Synapse
- Ibex Medical Analytics
- Hinge Health
- Meru Health
- NextGen Healthcare
- Nookal
- Open Dental
- Oracle Clinical One
- Phreesia
Other Healthcare software
Multi-finding chest X-ray and head CT triage AI with FDA clearance on named findings, not on the whole model
Pricing on request12 researched notesEnterprise imaging and PACS from a Swedish vendor that also sells the pathology and cardiology modules on one platform
Pricing on request12 researched notesGenerative reporting and follow-up tracking for radiology, positioned outside the diagnostic device boundary
Pricing on request12 researched notesFDA cleared and CE marked AI for mammography, tomosynthesis and chest radiography
Pricing on request11 researched notesAI digital pathology across clinical, veterinary and environmental laboratory disciplines
Pricing on request11 researched notesEnterprise radiology PACS and diagnostic image viewing from Philips
Pricing on request12 researched notesServer-side streaming PACS built for radiologists reading very large studies over thin connections
Pricing on request12 researched notesDigital pathology AI holding the first FDA De Novo authorisation for a pathology algorithm, now part of Tempus
Pricing on request12 researched notesFrench mammography AI with FDA clearances for 2D and tomosynthesis breast screening
Pricing on request11 researched notesEnterprise imaging platform covering PACS, VNA, cardiology and 3D from Fujifilm Healthcare
Pricing on request12 researched notesCancer detection AI for breast, prostate and gastric pathology deployed in routine clinical service, not just pilots
Pricing on request12 researched notesTwelve week therapist led mental health programme combining an app, a clinician and HRV biofeedback
Pricing on request12 researched notesAustralian allied health practice management priced per practitioner with usage charges on top
From A$49/mo12 researched notesUnified clinical trial data collection and randomisation on one Oracle Life Sciences platform
Pricing on request10 researched notesPatient intake, registration and payments platform for medical practices
Free plan9 researched notes
Softwr does not host reviews and shows no star rating for Gleamer, because a rating we did not collect is not ours to publish. What is here is the pricing and platform detail from the vendor’s own pages, limitations we could state concretely, and alternatives a reviewer confirmed people weigh against it. Tell us if any of it is wrong.
More on Gleamer
Gleamer alternatives
What people switch to, and what they give up
Gleamer pricing
Every tier, and where the cost actually lands
Compare Gleamer
Put it head to head with anything we hold
Gleamer badge
Its rating, and an embed for your own site
Best Healthcare software alternatives
Clinical laboratory middleware and informatics from a diagnostics instrument manufacturer
quote
Open source hospital information system and EMR for low-resource hospitals, built on OpenMRS
Open source, no licence fee
Period and cycle tracking app owned by German company Biowink, positioned around science based tracking and a published stance against sharing data with law enforcement
Free with a Plus subscription
Period and cycle tracking app that settled with the US FTC in 2021 over sharing health data with third parties despite promising not to
Free with a Premium subscription
Open source health information platform run from the University of Oslo and used by national ministries
Open source, no licence feeMulti-finding chest X-ray and head CT triage AI with FDA clearance on named findings, not on the whole model
quote